Remove tag policy-solutions
article thumbnail

Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference

The Pharma Data

How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19. This site uses cookies as described in our Cookie Policy. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. Learn More. Our Company. You are now leaving jnj.com.

article thumbnail

Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference

The Pharma Data

How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19. This site uses cookies as described in our Cookie Policy. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. Learn More. Our Company. You are now leaving jnj.com.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds October 21, 2022: Disinformation, Cyberthreat, and Choice: Protecting Patients and Clinical Research From the Digital Triple Threat (Eric Perakslis, PhD; Andrea Downing)

Rethinking Clinical Trials

Patients use the internet to search for answers, and researchers use the internet to search for new solutions. In a recent paper, Health advertising on Facebook: Privacy and Policy Considerations, patients download their raw data, and found who was tracking them across the internet. Data Security, Disinformation, Cyberthreat.

article thumbnail

Johnson & Johnson to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference

The Pharma Data

How We’re Mobilizing Our Resources to Help Find Solutions for COVID-19. This site uses cookies as described in our Cookie Policy. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. Learn More. Our Company. You are now leaving jnj.com.

article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Finding solutions.

article thumbnail

Ways IoT Has Transformed The Pulse Of Healthcare, And Will Continue To Do So In The Future

Delveinsight

Today the tech-based healthcare industry is providing many unique solutions to the patient’s care which are more efficient and effective than the traditional services. IoT relies on the data collected from devices and provides valuable insights that help in providing the best possible healthcare solution to the patient.

Doctors 59
article thumbnail

New Rare Disease Drugs and Research Advancements

XTalks

Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.